Heparin. Lexi-Drugs. Lexicomp.
Enoxaparin Lexi-Drugs. Lexicomp
Spinler, Sarah A. “Safety and tolerability of antiplatelet therapies for the secondary prevention of atherothrombotic disease.” Pharmacotherapy vol. 29,7 (2009): 812-21. doi:10.1592/phco.29.7.812
Protamine. Lexi-Drugs. Lexicomp
Epinephrine. Lexi-Drugs. Lexicomp
Warfarin. Lexi-Drugs. Lexicomp.
Protamine Side Effects. Drugs.com. June 9,2021.
Phytonadione. Lexi-Drugs. Lexicomp.
Khawar H, Kelley W, Stevens JB, et al. Fresh Frozen Plasma (FFP) [Updated 2021 Sep 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-.
Fresh frozen plasma information. Medscape.com [Internet]. 2015.
Kcentra. Lexi-Drugs. Lexicomp.
Apixaban. Lexi-Drugs. Lexicomp.
Rivaroxaban. Lexi-Drugs. Lexicomp
Dager, William E. “Developing a management plan for oral anticoagulant reversal.” American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists vol. 70,10 Suppl 1 (2013): S21-31. doi:10.2146/ajhp130042
Kalus, James S. “Pharmacologic interventions for reversing the effects of oral anticoagulants.” American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists vol. 70,10 Suppl 1 (2013): S12-21. doi:10.2146/ajhp130041
Feiba. Lexi-Drugs. Lexicomp.
Andexanet Alfa. Lexi-Drugs. Lexicomp.
Connolly, Stuart J et al. “Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors.” The New England journal of medicine vol. 380,14 (2019): 1326-1335. doi:10.1056/NEJMoa1814051
Kurogi, Ryota et al. “Comparing intracerebral hemorrhages associated with direct oral anticoagulants or warfarin.” Neurology vol. 90,13 (2018): e1143-e1149. doi:10.1212/WNL.0000000000005207
Steiner, Thorsten et al. “Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal Agents.” Stroke vol. 48,5 (2017): 1432-1437. doi:10.1161/STROKEAHA.116.013343
Frontera, Jennifer A et al. “Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine.” Neurocritical care vol. 24,1 (2016): 6-46. doi:10.1007/s12028-015-0222-x
Dabigatran. Lexi-Drugs. Lexicomp.
Dager, William E. “Developing a management plan for oral anticoagulant reversal.” American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists vol. 70,10 Suppl 1 (2013): S21-31. doi:10.2146/ajhp130042
Kalus, James S. “Pharmacologic interventions for reversing the effects of oral anticoagulants.” American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists vol. 70,10 Suppl 1 (2013): S12-21. doi:10.2146/ajhp130041
Schulman, Sam et al. “Activated prothrombin complex concentrate for dabigatran-associated bleeding.” British journal of haematology vol. 164,2 (2014): 308-10. doi:10.1111/bjh.12620
Idarucizumab. Lexi-Drugs. Lexicomp
Pollack, Charles V Jr et al. “Idarucizumab for Dabigatran Reversal - Full Cohort Analysis.” The New England journal of medicine vol. 377,5 (2017): 431-441. doi:10.1056/NEJMoa1707278